Alex Hammond is an Equity Research associate on the US Biopharmaceuticals team, covering Large & SMid Cap Biotech and Major Pharma. Prior to joining the firm, she was an intern at Guggenheim Securities covering Biotechnology. She has a PhD from NYU School of Medicine in Microbiology and a BS in Cell and Molecular Biology from Binghamton University.
Alexandria Hammond, PhD
Associate, Global Research, BofA Securities